ALLIANCE A091404

Primary Category:

Treatment Protocols

Disease Category:

Head and Neck

Status:

Closed

A Phase II Study of Enzalutamide (NSC# 766085) for Patients with Androgen Receptor Positive Salivary Cancers

NCT#02749903

Effective August 31, 2018, Alliance A091404 is closed to accrual.